Pharmacokinetic-Guided Therapeutic Dose Monitoring (TDM) of Busulfan Reduces Relapse of Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

被引：0
|
作者：
Hill, Brian T. [1 ]
Rybicki, Lisa [2 ]
Urban, Theresa A. [3 ]
Lucerna, Mariana [4 ]
Jagadeesh, Deepa [5 ]
Gerds, Aaron T. [5 ]
Dean, Robert M. [5 ]
Sobecks, Ronald M. [5 ]
Pohlman, Brad [5 ]
Bolwell, Brian [5 ]
Kalaycio, Matt E. [5 ]
Hamilton, Betty K. [5 ]
Copelan, Edward A. [6 ]
Majhail, Navneet S. [7 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
[3] Cleveland Clin, Pharm, Cleveland, OH 44106 USA
[4] Cleveland Clin, Dept Pharm, Cleveland, OH 44106 USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Blood & Marrow Transplantat, Cleveland, OH 44106 USA
[6] Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
[7] Cleveland Clin, Blood & Marrow Transplant Program, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
39
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
    Hill, Brian T.
    Rybicki, Lisa A.
    Urban, Theresa A.
    Lucena, Mariana
    Jagadeesh, Deepa
    Gerds, Aaron T.
    Dean, Robert M.
    Sobecks, Ronald M.
    Pohlman, Brad
    Bolwell, Brian
    Kalaycio, Matt E.
    Hamilton, Betty K.
    Copelan, Edward A.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (02) : 262 - 271
  • [2] Pulmonary mortality after high-dose oral busulfan and autologous stem cell transplant (ASCT) in patients with non-Hodgkin lymphoma (NHL).
    Kalaycio, M
    Pohlman, B
    Rybicki, L
    Sobecks, R
    Kuczkowski, E
    Andresen, S
    Brown, S
    Bolwell, B
    BLOOD, 2005, 106 (11) : 501A - 502A
  • [3] Autologous Stem Cell Transplantation (ASCT) Is Effective Therapy for Older Patients with Non-Hodgkin's Lymphoma (NHL)
    Jagadeesh, Deepa
    Rybicki, Lisa
    Abounader, Lonna
    Liu, Hein
    Dean, Robert M.
    Hill, Brian T.
    Sobecks, Ronald M.
    Gerds, Aaron
    Hamilton, Betty Ky
    Pohlman, Brad
    Kalaycio, Matt E.
    Bolwell, Brian
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S224 - S225
  • [4] Assessing Individual Comorbidities in Elderly Non-Hodgkin Lymphoma (NHL) Patients Undergoing Autologous Stem Cell Transplant (ASCT)
    Ip, Andrew
    Switchenko, Jeffrey M.
    Graiser, Michael
    Koff, Jean
    Gupta, Vikas
    Lechowicz, MaryJo
    Al-Kadhimi, Zaid
    Nooka, Ajay
    Kaufman, Jonathan
    Lonial, Sagar
    Waller, Edmund K.
    Langston, Amelia A.
    Flowers, Christopher
    Cohen, Jonathon B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S135 - S136
  • [5] Late relapses following autologous hematopoietic stem cell (ASCT) transplantation for non-Hodgkin's lymphoma (NHL).
    Bierman, PJ
    Vose, JM
    Lynch, JC
    Bociek, RG
    Morris, ME
    Armitage, JO
    BLOOD, 1999, 94 (10) : 610A - 610A
  • [6] HIV Status Does Not Affect the Outcome of Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma (NHL)
    Krishnan, Amrita
    Palmer, Joycelynne M.
    Zaia, John A.
    Tsai, Ni-Chun
    Alvarnas, Joseph
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) : 1302 - 1308
  • [7] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [8] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jae-Cheol Jo
    Jin Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Sung-Nam Lim
    Sang Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Sung Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Bone Marrow Transplantation, 2020, 55 : 1466 - 1468
  • [9] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [10] Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Won-Sik
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Choi, Yun Suk
    Bae, Seong Hwa
    BONE MARROW TRANSPLANTATION, 2019, 54 : 209 - 210
12345